TY - JOUR
T1 - EndoBridge 2024
T2 - pearls and highlights
AU - Yildiz, Bulent Okan
AU - Armeni, Eleni
AU - Balodimou, Chrysanthi
AU - Biondi, Bernadette
AU - Ciudin, Andreea
AU - Frühbeck, Gema
AU - Fuleihan, Ghada El Hajj
AU - Geer, Eliza B.
AU - Gillard, Pieter
AU - Gordon, Catherine M.
AU - Goulis, Dimitrios
AU - Hammer, Gary D.
AU - Höybye, Charlotte
AU - Langdahl, Bente Lomholt
AU - Laufer, Alexandra B.
AU - van der Lely, A. J.
AU - Macut, Djuro
AU - Mader, Julia K.
AU - McGowan, Barbara
AU - Novac, Eva
AU - Pignatelli, Duarte
AU - Pfeifer, Misa
AU - Radić, Lena
AU - Shah, Viral
AU - Stratakis, Constantine A.
AU - Treiber, Gerlies
AU - Vrachnis, Dionysios N.
AU - Wilding, John
AU - Yazici, Dilek
AU - Celik, Ozlem
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Hellenic Endocrine Society 2025.
PY - 2025/12
Y1 - 2025/12
N2 - EndoBridge 2024 was held from October 18–20, 2024, in Antalya, Türkiye. The scientific program of the 12th Annual Meeting of EndoBridge, accredited by the European Council, featured advanced lectures and interactive case discussion sessions in small groups, all delivered by internationally renowned experts in the field. The event attracted a wide range of attendees and offered an extensive overview of key topics in endocrinology and metabolism. These included pituitary, thyroid, bone, and adrenal diseases, neuroendocrine tumors, diabetes, obesity, nutrition, and lipid disorders. Abstracts of clinical cases presented during oral and poster sessions were published in JCEM Case Reports. This article summarizes the major highlights and key insights from the meeting, covering a broad spectrum of topics such as management of acromegaly, treatment of subclinical thyroid disease, goal-directed treatment for osteoporosis, the role of adjunctive therapies in type 1 diabetes mellitus, phenotyping obesities, hormonal management of menopause and premature ovarian failure, and updates on male hypogonadism and infertility. These discussions present the most recent advancements in endocrinology and offer clinical perspectives on prevalent endocrine conditions. The 13th Annual EndoBridge Meeting is scheduled to be held from October 23 to 26, 2025, in Antalya, Türkiye.
AB - EndoBridge 2024 was held from October 18–20, 2024, in Antalya, Türkiye. The scientific program of the 12th Annual Meeting of EndoBridge, accredited by the European Council, featured advanced lectures and interactive case discussion sessions in small groups, all delivered by internationally renowned experts in the field. The event attracted a wide range of attendees and offered an extensive overview of key topics in endocrinology and metabolism. These included pituitary, thyroid, bone, and adrenal diseases, neuroendocrine tumors, diabetes, obesity, nutrition, and lipid disorders. Abstracts of clinical cases presented during oral and poster sessions were published in JCEM Case Reports. This article summarizes the major highlights and key insights from the meeting, covering a broad spectrum of topics such as management of acromegaly, treatment of subclinical thyroid disease, goal-directed treatment for osteoporosis, the role of adjunctive therapies in type 1 diabetes mellitus, phenotyping obesities, hormonal management of menopause and premature ovarian failure, and updates on male hypogonadism and infertility. These discussions present the most recent advancements in endocrinology and offer clinical perspectives on prevalent endocrine conditions. The 13th Annual EndoBridge Meeting is scheduled to be held from October 23 to 26, 2025, in Antalya, Türkiye.
KW - Adrenal
KW - Bone
KW - Diabetes mellitus
KW - Obesity
KW - Pituitary
KW - Thyroid
UR - https://www.scopus.com/pages/publications/105012735728
U2 - 10.1007/s42000-025-00708-5
DO - 10.1007/s42000-025-00708-5
M3 - Review article
C2 - 40768135
AN - SCOPUS:105012735728
SN - 1109-3099
VL - 24
SP - 923
EP - 946
JO - Hormones
JF - Hormones
IS - 4
ER -
SKH 3 Sağlık ve Kaliteli Yaşam